1. 2 Effects of sorafenib treatment on HNSCC cells in combination with cisplatin based-chemoradiation. Issue 5 (May 2015) Authors: Kriegs, M.; Dikomey, E.; Knecht, R. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2 Effects of sorafenib treatment on HNSCC cells in combination with cisplatin based-chemoradiation. Issue 5 (May 2015) Authors: Möckelmann, N.; Kriegs, M.; Dikomey, E.; Knecht, R. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2 Effects of sorafenib treatment on HNSCC cells in combination with cisplatin based-chemoradiation. Issue 5 (May 2015) Authors: Möckelmann, N.; Kriegs, M.; Dikomey, E.; Knecht, R. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PH-0236: CD44v3-10 affects G2-arrest and radiosensitivity of S-phase cells via homologous recombination. (November 2020) Authors: Al Bazaz, M.; Lerch, S.; Hannen, R.; Lauber, K.; Dikomey, E.; Engenhart-Cabillic, R.; Schötz, U. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PH-0478: HPV pos HNSCC cells show strong radiosensitivity after photon but not after carbon ion irradiation. (November 2020) Authors: Lerch, S.; Berthold, S.; Ziemann, F.; Dreffke, K.; Subtil, F.; Jensen, A.; Engenhart-Cabillic, R.; Dikomey, E.; Wittig, A.; Eberle, F.; Schötz, U. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0745: Switch to PARP1-dependent endjoining: Olaparib-mediated radiosensitization in prostate cancer cells. (April 2015) Authors: Petersen, C.; Mansour, W.Y.; Koetter, A.; Dikomey, E. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1083 The dual inhibitor BEZ235 radiosensitizes HNSCC cells due to impairment of the DSB repair. (April 2019) Authors: Arenz, A.; Balzer, V.; Dreffke, K.; Rieckmann, T.; Köcher, S.; Dikomey, E.; Engenhart-Cabillic, R.; Wittig, A.; Schötz, U. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗